Atlas Trials

PepGen Inc

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch PepGen Inc

RecordFirmDate
An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE) (NCT07220603)PepGen Inc2025-12-23
A Study of PGN-EDO51 or Placebo in People With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment (NCT06833931)PepGen Inc2024-12-17
A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (NCT06667453)PepGen Inc2024-12-10
A Study Of PGN-EDO51 In Participants With Duchenne Muscular Dystrophy Amenable To Exon 51-Skipping Treatment (NCT06079736)PepGen Inc2024-01-03
Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1 (NCT06204809)PepGen Inc2023-12-12

Track PepGen Inc automatically

Every clearance here is in the API, with alerts when new ones post.